Development and validation of a predictive score to identify K-Ras wild-type (WT) metastatic colorectal cancer (mCRC) patients who are likely to benefit from Panitumumab (P) treatment. This is an ASCO ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results